Learn with Anil · APPSC Group-I PYQsPractise online →Subscribe ₹149
LVM3 lifting off with Chandrayaan-3 from Sriharikota, Andhra Pradesh

Photo: LVM3 launch, Sriharikota, ISRO, GODL-India

APPSC Group-I Mains 2020 · Paper V

2020 Paper V · Q7(b): model answer

Science, Technology & Environmental Issues · Biotechnology and health. Held in December 2020 (Notification 27/2018).

Q7(b)10 marks2020 · Paper V

In October 2020, the Nobel Prize for Chemistry was awarded to the CRISPR technology. Explain how CRISPR functions in nature and how it has been adapted for research and clinical applications.

Syllabus: Biotechnology and health · Biotechnology

Model answer · free

CRISPR-Cas9Bacterial immunityGuide RNAGenome editing

The 2020 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for developing CRISPR-Cas9, the "genetic scissors" that can cut DNA at almost any chosen site. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a stretch of bacterial DNA that, together with Cas (CRISPR-associated) proteins, forms a natural immune system against viruses that infect bacteria (bacteriophages).

1. How CRISPR functions in nature

  • Memory (adaptation): when a phage attacks, Cas proteins snip a short piece of its DNA and insert it as a spacer between the repeats of the bacterium's CRISPR array, a genetic record of past infections.
  • Expression: the array is copied into RNA and cut into short CRISPR RNAs; in the Cas9 system a second RNA, tracrRNA (discovered by Charpentier), pairs with each of them.
  • Interference: on a fresh attack, the RNA guides Cas9 to the matching viral DNA, and Cas9 cuts both strands, disabling the virus. A short "PAM" sequence next to the target tells Cas9 that the DNA is foreign, so the bacterium does not cut its own array.
Phage injects itsDNABacterium stores apiece as a spacerSpacer copied intoa guide RNACas9 and guide RNAfind matchingviral DNACas9 cuts it;memory kept forthe next attackCRISPR immunity inbacteria

2. Adaptation for research

  • Programmable scissors (2012): Charpentier and Doudna fused the two RNAs into a single guide RNA. By changing its 20-letter sequence, scientists can send Cas9 to any gene in any organism.
  • Repair does the editing: the cell mends the cut either by joining the ends, which often disables (knocks out) the gene, or by copying a supplied template, which makes a precise correction or insertion.
  • Wider toolkit: "dead" Cas9 switches genes on or off without cutting; base and prime editors change single letters; Cas12a and Cas13 target DNA and RNA.
  • Uses: finding gene functions, making disease models in mice and organoids, screening drug targets and breeding crops: India's genome-edited rice varieties Kamala and Pusa DST Rice 1 (May 2025).

3. Clinical and diagnostic applications

FieldApplicationExample
MedicineEdit a patient's blood stem cells outside the body and return themCasgevy (first approved in 2023) for sickle cell disease and beta-thalassaemia
Medicine in IndiaIndigenous CRISPR therapyBIRSA 101 (CSIR-IGIB, enFnCas9; November 2025) for sickle cell disease
CancerEngineer immune cells to attack tumoursEdited CAR-T cells in trials
DiagnosticsCas enzymes detect viral genesFELUDA paper-strip Covid-19 test (CSIR-IGIB, 2020)
AgricultureEdits without foreign DNA (SDN-1, SDN-2)DRR Dhan 100 (Kamala), Pusa DST Rice 1
From bacterial defence to applications
  • Casgevy reactivates fetal haemoglobin, freeing many patients from regular blood transfusions; it was the world's first approved CRISPR medicine.
  • In-body editing delivers CRISPR directly to the liver or eye and is in clinical trials abroad.

4. Concerns

  • Off-target cuts and incomplete editing; very high cost (Casgevy costs over US$2 million in the USA).
  • Germline editing is banned in India; the 2018 gene-edited babies in China showed the danger.
  • Patent disputes and biosafety of gene drives in the wild.

AP angle: the genome-edited Kamala rice was derived from Samba Mahsuri, bred at Bapatla, and sickle cell disease, common among tribal communities including those of AP's Agency areas, is the first target of India's CRISPR therapy.

From a bacterial defence to a medicine, CRISPR shows how basic research becomes precision medicine. Affordable access and strict ethical oversight will decide its benefits.

The other choice in Q7

Answer either one in the exam.

  1. Q7(a)Is there any difference between gene therapy, transgenic organisms, and gene enhancement/genome editing? With example, explain the ethical concerns in each of these approaches? When can genome editing be considered ethical?

    10 marks · Biotechnology and health · Biotechnology

Write better answers: the Answer Writing Tool Kit

Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149